AIDOC RAISES $150M IN SERIES E FUNDING

Aidoc's latest funding round reflects growing investment in AI-powered medical imaging tools designed to improve diagnostic efficiency and patient outcomes. The platform assists radiologists by automatically detecting and highlighting incidental findings—unexpected discoveries unrelated to the original reason for imaging—on cross-sectional imaging studies. Incidental findings on medical scans are common but often go unaddressed during initial reviews. Aidoc's software aims to reduce missed diagnoses by alerting clinicians to potential abnormalities that warrant further investigation. The company joins a competitive field of medical AI startups securing substantial funding. Series E valuations typically indicate investor confidence in market traction and scaling potential. Aidoc's cumulative $520 million in funding demonstrates sustained confidence from backers in the commercial viability of AI-assisted radiology tools. The healthcare AI market continues expanding as hospitals seek technologies to address radiologist shortages and improve diagnostic accuracy.